MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

RSV vaccine

  • Study Reveals Why COVID-19 Vaccine Antibodies Wane Rapidly
    Study Reveals Why COVID-19 Vaccine Antibodies Wane Rapidly
    Research shows that, unlike tetanus and influenza vaccines, COVID-19 mRNA vaccines do not prompt the generation of durable antibody-producing cells.
    November 13, 2024BY Marina Zhang
  • RSV Vaccines May Increase Risk of Rare Neurological Condition
    RSV Vaccines May Increase Risk of Rare Neurological Condition
    CDC officials are investigating a potential link between two recently approved RSV vaccines and increased reports of Guillain-Barré ...
    March 4, 2024BY Megan Redshaw
  • Australia Approves First Vaccine for Infectious Respiratory Virus for Over 60s
    Australia Approves First Vaccine for Infectious Respiratory Virus for Over 60s
    2023 saw increases in reported cases of RSV when compared with 2022, with large numbers being seen in ...
    January 16, 2024BY Jim Birchall
  • White House Confirms 230,000 Additional RSV Immunization Doses for Infants Next Month
    White House Confirms 230,000 Additional RSV Immunization Doses for Infants Next Month
    Low infant death rates from RSV and concerns about the safety of treatment have cast doubts about the ...
    December 21, 2023BY Naveen Athrappully
  • Study: Moderna’s mRNA-Based RSV Vaccine Causes High Rate of Adverse Reactions
    Study: Moderna’s mRNA-Based RSV Vaccine Causes High Rate of Adverse Reactions
    The vaccine group suffered roughly 81 adverse events for every RSV illness the jab prevented.
    December 19, 2023BY Naveen Athrappully
  • Vaccine Toxicity, 3-Foot Long Blood Clots, COVID Testing—Panel Answers Critical Questions | Florida Summit
    Vaccine Toxicity, 3-Foot Long Blood Clots, COVID Testing—Panel Answers Critical Questions | Florida Summit
    A physically active lawmaker at the Florida House of Representatives was diagnosed with a huge blood clot from ...
    December 8, 2023BY Dan Skorbach
  • Pfizer Failed to Disclose Risks of Preterm Birth and Neonatal Death to Pregnant Women in RSV Vaccine Trial
    Pfizer Failed to Disclose Risks of Preterm Birth and Neonatal Death to Pregnant Women in RSV Vaccine Trial
    A BMJ investigation revealed Pfizer was studying preterm births as an "adverse event of special interest" in RSV ...
    November 22, 2023BY Megan Redshaw
  • ‘Perfectly Reasonable to Skip’ COVID-19, Flu, RSV Fall Vaccines: Dr. McCullough
    ‘Perfectly Reasonable to Skip’ COVID-19, Flu, RSV Fall Vaccines: Dr. McCullough
    The cardiologist advised people to seek ‘early treatment’ for such infections rather than getting vaccinated.
    October 21, 2023BY Naveen Athrappully
TOP NEWS
  • Trump to Meet Putin, Xi on Sidelines of APEC Next Week, Officials Say
    NEW By Troy Myers
    Trump to Meet Putin, Xi on Sidelines of APEC Next Week, Officials Say
  • Van Hollen Makes His Case to Replace Schumer as Jeffries Is Heckled at Democratic Gathering
    1hr By Chase Smith
    Van Hollen Makes His Case to Replace Schumer as Jeffries Is Heckled at Democratic Gathering
  • Nvidia Shares Fall for a 2nd Day in Fallout From CEO Resignation
    1hr By Bill Pan
    Nvidia Shares Fall for a 2nd Day in Fallout From CEO Resignation
  • Tanker Collides With Docked Riverboat in New Orleans
    2hr By Jacki Thrapp
    Tanker Collides With Docked Riverboat in New Orleans
  • FAA Grounds All Flights Across the US
    3hr By Jill McLaughlin
    FAA Grounds All Flights Across the US
  • Supreme Court Takes Up Robinhood Investor Lawsuit
    4hr By Stacy Robinson
    Supreme Court Takes Up Robinhood Investor Lawsuit
  • Supreme Court to Consider Trump’s Asylum Restrictions at Southern Border
    5hr By Jack Phillips
    Supreme Court to Consider Trump’s Asylum Restrictions at Southern Border
  • Cisco Sued in California Over Alleged Link to Human Rights Abuses
    5hr By Eva Fu
    Cisco Sued in California Over Alleged Link to Human Rights Abuses
  • DOJ Says Agencies Should Prioritize English Over Other Languages
    6hr By Jack Phillips
    DOJ Says Agencies Should Prioritize English Over Other Languages
  • Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
    6hr By Victoria Friedman
    Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top